EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implantation of Islets Co-Seeded with Tregs in a Novel Biomaterial Reverses Diabetes in the NOD Mouse Model

Diana M Elizondo, Lais L de Oliveira Rekowsky, Ayane de Sa Resende, Jonathan Seenarine, Ricardo Luis Louzada da Silva, Jamel Ali, Dazhi Yang, Tatiana de Moura, Michael W Lipscomb

Tissue Engineering and Regenerative Medicine · 2025

DOI: 10.1007/s13770-024-00685-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, 2025. Verfasst von Diana M Elizondo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, 21250, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Mice, Inbred NOD, Diabetes Mellitus, Type 1, Biocompatible Materials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 1 diabetes (T1D) results in autoreactive T cells chronically destroying pancreatic islets. This often results in irreplaceable loss of insulin-producing beta cells. To reverse course, a combinatorial strategy of employing glucose-responsive insulin restoration coupled with inhibiting autoreactive immune responses is required.

Methods

Non-obese diabetic mice received a single intraperitoneal implantation of a novel biomaterial co-seeded with insulin-producing islets and T regulatory cells (Tregs). Controls included biomaterial seeded solely with islets, or biomaterial only groups. Mice were interrogated for changes in inflammation and diabetes progression via blood glucose monitoring, multiplex serum cytokine profiling, flow cytometry and immunohistochemistry assessments.

Results

Islet and Tregs co-seeded biomaterial recipients had increased longevity, insulin secretion, and normoglycemia through 180 days post-implantation compared to controls. Serum profile revealed reduced TNFα, IFNγ, IL-1β and increased IL-10, insulin, C-Peptide, PP and PPY in recipients receiving co-seeded biomaterial. Evaluation of the resected co-seeded biomaterial revealed reduced infiltrating autoreactive CD8 + and CD4 + T cells concomitant with sustained presence of Foxp3 + Tregs; further analysis revealed that the few infiltrated resident effector CD4 + or CD8 + T cells were anergic, as measured by low levels of IFNγ and Granzyme-B upon stimulation when compared to controls. Interestingly, studies also revealed increased Tregs in the pancreas. However, there was no restoration of the pancreas beta cell compartment, suggesting normoglycemia and production of insulin levels were largely supported by the implanted co-seeded biomaterial.

Conclusion

These studies show the efficacy of a combinatorial approach seeding Tregs with pancreatic islets in a novel self-assembling organoid for reversing T1D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryMice, Inbred NODDiabetes Mellitus, Type 1Biocompatible MaterialsIslets of LangerhansIslets of Langerhans TransplantationAnimalsMiceDisease Models, AnimalFemaleInsulinCytokinesBlood Glucose

Stichwörter der Autor:innen

BiomaterialNODTregs

Substanzen

Biocompatible MaterialsInsulinCytokinesBlood Glucose

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, 21250, USA.
  • Department of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA.
  • Department of Morphology, Federal University of Sergipe, São Cristóvão, Brazil.
  • Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, FL, 32310, USA.
  • Acrogenic Technologies Inc., Rockville, MD, 20850, USA.
  • Department of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA. lips0046@umn.edu.

Förderung

  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Elizondo, D. M., de Oliveira Rekowsky, L. L., de Sa Resende, A., Seenarine, J., da Silva, R. L. L., Ali, J., Yang, D., de Moura, T., & Lipscomb, M. W. (2025). Implantation of Islets Co-Seeded with Tregs in a Novel Biomaterial Reverses Diabetes in the NOD Mouse Model. Tissue Engineering and Regenerative Medicine. https://doi.org/10.1007/s13770-024-00685-7

Vancouver

Elizondo DM, de Oliveira Rekowsky LL, de Sa Resende A, Seenarine J, da Silva RLL, Ali J, et al. Implantation of Islets Co-Seeded with Tregs in a Novel Biomaterial Reverses Diabetes in the NOD Mouse Model. Tissue Engineering and Regenerative Medicine. 2025. doi:10.1007/s13770-024-00685-7

BibTeX
@article{Elizondo2025,
  author = {Elizondo, Diana M and de Oliveira Rekowsky, Lais L and de Sa Resende, Ayane and Seenarine, Jonathan and da Silva, Ricardo Luis Louzada and Ali, Jamel and Yang, Dazhi and de Moura, Tatiana and Lipscomb, Michael W},
  title = {Implantation of Islets Co-Seeded with Tregs in a Novel Biomaterial Reverses Diabetes in the NOD Mouse Model},
  journal = {Tissue Engineering and Regenerative Medicine},
  year = {2025},
  doi = {10.1007/s13770-024-00685-7}
}
Kostenlos starten →